Singapore state investor Temasek has backed the £195 million ($271 million) funding round in Nanopore Technologies, a UK-headquartered DNA sequencing firm that plans to go public later this year, according to an announcement.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in